Vanguard Group’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $28M | Buy |
|
|||||
|
2018
Q2 | $30.3M | Buy |
|
|||||
|
2018
Q1 | $31.8M | Sell |
|
|||||
|
2017
Q4 | $36.7M | Buy |
|
|||||
|
2017
Q3 | $53.7M | Buy |
|
|||||
|
2017
Q2 | $52M | Buy |
|
|||||
|
2017
Q1 | $42.2M | Buy |
|
|||||
|
2016
Q4 | $38.4M | Buy |
|
|||||
|
2016
Q3 | $34M | Buy |
|
|||||
|
2016
Q2 | $41.1M | Sell |
|
|||||
|
2016
Q1 | $29M | Buy |
|
|||||
|
2015
Q4 | $30.3M | Sell |
|
|||||
|
2015
Q3 | $25M | Buy |
|
|||||
|
2015
Q2 | $68.6M | Buy |
|
|||||
|
2015
Q1 | $83.2M | Buy |
|
|||||
|
2014
Q4 | $80.5M | Buy |
|
|||||
|
2014
Q3 | $76.9M | Buy |
|
|||||
|
2014
Q2 | $64M | Buy |
|
|||||
|
2014
Q1 | $70.2M | Buy |
|
|||||
|
2013
Q4 | $31.9M | Buy |
|
|||||
|
2013
Q3 | $23.2M | Buy |
|
|||||
|
2013
Q2 | $16.9M | Buy |
|